Stroke Trial, Recruiting (NCT03452202)

Stroke Trial, Recruiting NCT03452202 Sponsor: NYU Langone Health Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT03452202 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are right-handed
People who speak English as their only language
People who have had a single stroke affecting the left side of the brain
People who are at least six months past their stroke
People who have been clinically diagnosed with apraxia of speech (a motor speech disorder caused by brain damage)
People who have normal speech perception (the ability to hear and understand speech sounds)
People who pass a hearing screening test

Who may not be able to join:

People who have a diagnosed voice disorder affecting the voice box (larynx)
People who have dysarthria (a muscle-related speech disorder)
People who had a speech impairment before their stroke
People who have damaged skin at the area of the body where the brain stimulation device would be placed
People who have an implanted device that runs on electricity or magnetism, such as a pacemaker
People who have any metal anywhere in their body
People who have a family history of epilepsy that does not respond to medication
People who have a personal history of seizures or unexplained episodes of loss of consciousness

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03452202

Sponsor: NYU Langone Health

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

More information: https://clinicaltrials.gov/study/NCT03452202

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are right-handed
People who speak English as their only language
People who have had a single stroke affecting the left side of the brain
People who are at least six months past their stroke
People who have been clinically diagnosed with apraxia of speech (a motor speech disorder caused by brain damage)
People who have normal speech perception (the ability to hear and understand speech sounds)
People who pass a hearing screening test

Who may not be able to join:

People who have a diagnosed voice disorder affecting the voice box (larynx)
People who have dysarthria (a muscle-related speech disorder)
People who had a speech impairment before their stroke
People who have damaged skin at the area of the body where the brain stimulation device would be placed
People who have an implanted device that runs on electricity or magnetism, such as a pacemaker
People who have any metal anywhere in their body
People who have a family history of epilepsy that does not respond to medication
People who have a personal history of seizures or unexplained episodes of loss of consciousness

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

NYU Langone Health

Registry

ClinicalTrials.gov

Start date

11 January 2019

Est. completion

30 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in accuracy in recordings from tasks from baseline to post treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov